Venter, J., & Blackie, M. A. L. (2019). Design, synthesis and biological activity studies of 1-aryl-3-(4-methoxybenzyl)ureas as proposed irreversible GSK-3 inhibitors in Alzheimer’s disease therapeutic development. Stellenbosch : Stellenbosch University.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Venter, Jana, and Margaret A. L. Blackie. Design, Synthesis and Biological Activity Studies of 1-aryl-3-(4-methoxybenzyl)ureas as Proposed Irreversible GSK-3 Inhibitors in Alzheimer’s Disease Therapeutic Development. Stellenbosch : Stellenbosch University, 2019.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Venter, Jana, and Margaret A. L. Blackie. Design, Synthesis and Biological Activity Studies of 1-aryl-3-(4-methoxybenzyl)ureas as Proposed Irreversible GSK-3 Inhibitors in Alzheimer’s Disease Therapeutic Development. Stellenbosch : Stellenbosch University, 2019.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.